← FDA DRUG APPROVALS

FDA ANDA · ANDA075969

METFORMIN HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA075969
TYPE
ANDA
ORIGINAL APPROVAL
2002-01-29
LATEST ACTION
2019-11-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 850MG · TABLET · ORAL
METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 1GM · TABLET · ORAL
METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 500MG · TABLET · ORAL

Approval history

2019-11-14Labeling · Supplement 11 · standardAP
2019-11-14Labeling · Supplement 12 · standardAP
2007-06-08Labeling · Supplement 9AP
2004-06-18Labeling · Supplement 5AP
2003-01-02Labeling · Supplement 2AP
2002-11-06Manufacturing (CMC) · Supplement 1AP
2002-01-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →